Central Admixture Pharmacy Services Inc: Drug Recall

Recall #D-0016-2024 · 09/21/2023

Class II: Risk

Recall Details

Recall Number: D-0016-2024
Classification: Class II
Product Type: Drug
Recalling Firm: Central Admixture Pharmacy Services Inc
Status: Terminated
Date Initiated: 09/21/2023
Location: San Diego, CA, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 60 250 mL bags

Reason for Recall

Lack of assurance of sterility:

Product Description

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1

Distribution Pattern

Nationwide in the USA

Other Recalls by Central Admixture Pharmacy Services Inc

Class I: Dangerous 02/20/2025

Presence of Particulate Matter
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:

View all recalls by Central Admixture Pharmacy Services Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.